PWAM
GMAB icon

Private Wealth Asset Management’s Genmab GMAB Stock Holding History

Private Wealth Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$961 Hold
35
– – ﹤0.01% 892
2026
Q1 		$939 Hold
35
– – ﹤0.01% 875
2025
Q4 		$1.08K Hold
35
– – ﹤0.01% 861
2025
Q3 		$1.07K Hold
35
– – ﹤0.01% 848
2025
Q2 		$723 Hold
35
– – ﹤0.01% 871
2025
Q1 		$685 Buy
+35
New +$734 ﹤0.01% 958

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Private Wealth Asset Management's GMAB Position: Q2 2026 in Review

Private Wealth Asset Management held its Genmab (GMAB) position steady in Q2 2026 at 35 shares worth $961. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Private Wealth Asset Management first reported a position in GMAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.08K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Private Wealth Asset Management held 35 shares of Genmab worth $961 as of Q2 2026.
  • Private Wealth Asset Management left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #892 holding.
  • Private Wealth Asset Management first reported a position in Genmab in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Asset Management's Genmab position peaked at $1.08K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.